BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen YY, Yen HH, Chou KC, Wu SS. Thalidomide-based multidisciplinary treatment for patients with advanced hepatocellular carcinoma: A retrospective analysis. World J Gastroenterol 2012; 18(5): 466-471 [PMID: 22346253 DOI: 10.3748/wjg.v18.i5.466]
URL: https://www.wjgnet.com/1007-9327/full/v18/i5/466.htm
Number Citing Articles
1
Cheng‐Hung Chien, Rong‐Nan Chien. Thalidomide induces complete remission of advanced hepatocellular carcinomaAdvances in Digestive Medicine 2014; 1(2): 64 doi: 10.1016/j.aidm.2014.03.002
2
Natsuki Kurokawa, Taro Kishimoto, Kohei Tanaka, Jun Kondo, Nobuhiro Takahashi, Yutaka Miura. New approach to evaluating the effects of a drug on protein complexes with quantitative proteomics, using the SILAC method and bioinformatic approachBioscience, Biotechnology, and Biochemistry 2019; 83(11): 2034 doi: 10.1080/09168451.2019.1637244
3
FAN LIN, JIE CAO, ZHIMING HUANG, ZHENGHAO PEI, WEILI GU, SHAOFENG FAN, KUNPING LI, JIEFENG WENG. Effect of thalidomide on the proliferation of hepatoma cells assessed by osteopontin levels in nude miceExperimental and Therapeutic Medicine 2013; 5(5): 1403 doi: 10.3892/etm.2013.1010
4
Michael J. Nutt, Yeung Sing Yee, Amanda Buyan, Neil Andrewartha, Ben Corry, George C.T. Yeoh, Scott G. Stewart. In pursuit of a selective hepatocellular carcinoma therapeutic agent: Novel thalidomide derivatives with antiproliferative, antimigratory and STAT3 inhibitory propertiesEuropean Journal of Medicinal Chemistry 2021; 217: 113353 doi: 10.1016/j.ejmech.2021.113353
5
Qing Li, Yong Liu, Yang Yu. Antiangiogenic therapy for primitive neuroectodermal tumor with thalidomideMedicine 2017; 96(51): e9272 doi: 10.1097/MD.0000000000009272
6
Tao Wang, Qiting Zhang, Ning Wang, Ziqi Liu, Bin Zhang, Yufen Zhao. Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular CarcinomaCurrent Medicinal Chemistry 2021; 28(16): 3107 doi: 10.2174/0929867327666201013162144